FDA Clearance Tracker · P100049-S033
LINX Reflux Management System
Last checked: Nov 20, 2026Latest source record: Oct 4, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Oct 4, 2022
Approved
Time to decision
179 days
Received Apr 8, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P100049-S033
- Device name
- LINX Reflux Management System
- Applicant
- Torax Medical
- Applicant location
- Cincinnati, OH
- Received
- Apr 8, 2022
- Decided
- Oct 4, 2022
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P100049
Device type
- Device type
- IMPLANT, ANTI-GASTROESOPHAGEAL REFLUX (LEI)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for the following labeling updates: 1) inclusion of final post-approval study results; 2) addition of a precaution based on RELIEF study results; 3) addition of swallow-induced syncope to the list of adverse events; and 4) revised registered/trademark status.
Source documents
Other decisions for Torax Medical
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K230089 · Decided Feb 9, 2023 · 28 days after receipt
Device type: Laparoscopic Accessories, Esophageal Sizing (QJN) · GI, Urology & Nephrology
K201035 · Decided Jul 9, 2020 · 80 days after receipt
Device type: Laparoscopic Accessories, Esophageal Sizing (QJN) · GI, Urology & Nephrology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.